Trial · NCT07882836
Bilateral Pecto-Intercostal Fascial Plane Block for Prevention of Chronic Poststernotomy Pain After CABG
NCT07882836, Not applicable, Not yet recruiting, Izmir Katip Celebi University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Bilateral Pecto-Intercostal Fascial Plane Block for Prevention of Chronic Poststernotomy Pain After CABG. Trials, record NCT07882836. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07882836
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Bilateral Pecto-Intercostal Fascial Plane Block for Prevention of Chronic Poststernotomy Pain After CABG
- NCT number
- NCT07882836
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 180 participants, estimated
- Lead sponsor
- Izmir Katip Celebi University
- Conditions
- Chronic Poststernotomy Pain
- Interventions
- Pecto-Intercostal Fascial Plane Block, Standardized Multimodal Systemic Analgesia
- First posted
- 2026-10-20
- Last updated
- 2026-10-20
Source ClinicalTrials.gov
Registered outcomes32
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of Clinically Significant Chronic Poststernotomy Pain | Postoperative Day 90 | The proportion of participants with clinically significant chronic poststernotomy pain on postoperative day 90 will be assessed. Clinically significant chronic poststernotomy pain will be defined as pain that develops after surgery or is aggravated by surgery; is localized to the sternotomy line, parasternal region, chest tube insertion sites, or thoracic wall area related to internal thoracic artery dissection; persists or recurs at 3 months after surgery; and has an average intensity of at least 3 on the 0-10 Numeric Rating Scale (NRS) during the preceding 7 days. Pain better explained by sternal wound infection, mediastinitis, sternal instability or nonunion, recurrent myocardial ischemia, malignancy, or another clinical condition will not be classified as chronic poststernotomy pain. The outcome will be assessed by an outcome assessor blinded to treatment allocation. Higher incidence indicates a less favorable outcome. |
| Secondary | Postoperative Pain Intensity at Rest | 6, 12, 24, 48, and 72 hours after surgery and postoperative day 5, or at hospital discharge if discharge occurs before postoperative day 5 | Pain intensity at rest will be assessed using the 0-10 Numeric Rating Scale, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity. |
| Secondary | Postoperative Pain Intensity During Coughing or Deep Breathing | 6, 12, 24, 48, and 72 hours after surgery and postoperative day 5, or at hospital discharge if discharge occurs before postoperative day 5 | Pain intensity during coughing or deep breathing will be assessed using the 0-10 Numeric Rating Scale, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity. |
| Secondary | Postoperative Pain Intensity During Mobilization | 6, 12, 24, 48, and 72 hours after surgery and postoperative day 5, or at hospital discharge if discharge occurs before postoperative day 5 | Pain intensity during mobilization will be assessed using the 0-10 Numeric Rating Scale, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity. Mobilization pain will be assessed only when mobilization is clinically feasible. |
| Secondary | Intraoperative Opioid Consumption | Intraoperative period | Total opioid consumption administered during surgery will be recorded and converted to morphine milligram equivalents (MME). Higher values indicate greater opioid consumption. |
| Secondary | Requirement for Rescue Analgesia | From the end of surgery through postoperative day 5 or hospital discharge, whichever occurs first | The proportion of participants requiring at least one rescue analgesic intervention will be recorded. The protocol-defined primary criterion for rescue analgesia is a score of 4 or higher on the 0-10 Numeric Rating Scale (NRS) at rest or during coughing or movement; rescue analgesia may also be administered according to clinical need irrespective of the NRS threshold. |
| Secondary | Number of Rescue Analgesic Administrations | From the end of surgery through postoperative day 5 or hospital discharge, whichever occurs first | The total number of rescue analgesic administrations received by each participant during the assessment period will be recorded. Higher values indicate greater rescue analgesic requirements. |
| Secondary | Time to First Rescue Analgesia | From the end of surgery through postoperative day 5 or hospital discharge, whichever occurs first | Time from the end of surgery to the first administration of rescue analgesia will be recorded in hours. Participants who do not require rescue analgesia during the observation period will be recorded as having no rescue analgesic event during that period. |
| Secondary | Incidence of Postoperative Nausea | From the end of surgery through 120 hours after surgery or hospital discharge, whichever occurs first | The proportion of participants experiencing at least one episode of postoperative nausea during the assessment period will be recorded. |
| Secondary | Incidence of Postoperative Oversedation | From the end of surgery through 5 days after surgery or hospital discharge, whichever occurs first | The proportion of participants experiencing at least one episode of clinically significant oversedation during the assessment period will be recorded. Oversedation will be defined as inability to be easily awakened, requirement for repeated stimulation, or sedation sufficiently severe to cause clinically significant impairment of communication. |
1 to 10 of 32Source ClinicalTrials.gov
See all 32 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07882836
GET https://conductscience.org/api/trials/v1/NCT07882836/registered?page=2